EMBARQ Trademark

Trademark Overview

On Tuesday, November 19, 2013, a trademark application was filed for EMBARQ with the United States Patent and Trademark Office. The USPTO has given the EMBARQ trademark a serial number of 86122467. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 7, 2017. This trademark is owned by Glaxo Group Limited. The EMBARQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
embarq

General Information

Serial Number86122467
Word MarkEMBARQ
Filing DateTuesday, November 19, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 7, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 6, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 14, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, August 7, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 7, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2016EXTENSION 5 GRANTED
Friday, December 16, 2016EXTENSION 5 FILED
Friday, December 16, 2016TEAS EXTENSION RECEIVED
Tuesday, July 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 9, 2016EXTENSION 4 GRANTED
Tuesday, June 28, 2016EXTENSION 4 FILED
Tuesday, June 28, 2016TEAS EXTENSION RECEIVED
Tuesday, February 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 8, 2016EXTENSION 3 GRANTED
Tuesday, December 22, 2015EXTENSION 3 FILED
Sunday, February 7, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 22, 2015TEAS EXTENSION RECEIVED
Friday, June 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 25, 2015EXTENSION 2 GRANTED
Tuesday, June 2, 2015EXTENSION 2 FILED
Thursday, June 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 2, 2015TEAS EXTENSION RECEIVED
Thursday, November 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 18, 2014EXTENSION 1 GRANTED
Tuesday, November 18, 2014EXTENSION 1 FILED
Tuesday, November 18, 2014TEAS EXTENSION RECEIVED
Tuesday, July 1, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 6, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 6, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 2, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 2, 2014ASSIGNED TO LIE
Friday, March 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 13, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 12, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 12, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 3, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 3, 2014NON-FINAL ACTION E-MAILED
Monday, March 3, 2014NON-FINAL ACTION WRITTEN
Monday, March 3, 2014REMOVED FROM TEAS PLUS
Friday, February 28, 2014ASSIGNED TO EXAMINER
Tuesday, December 3, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 22, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

embarq pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological